Upneeq®

Oxymetazoline Hydrochloride 0.1%
ophthalmic solution
Aesthetics/Presbyopia
[ Alpha-Adrenergic Agonist]
Indication

Indication

Treatment of acquired blepharoptosis in adults
Mechanism of Action

Mechanism of Action

Targets adrenoreceptors in Mueller’s muscle of the eyelid, causing elevation of the upper eyelid.
Common quantities available

Available Quantities

30 and 45 single patient-use containers
Dosage

Dosage/Instructions

Instill 1 drop into 1 or both ptotic eye(s) once daily. Discard the single patient-use container immediately after dosing. Contact lenses should be removed prior to instillation and may be reinserted 15 minutes following administration.
Pregnancy & Nursing Data

Pregnancy & Nursing

No data on use in pregnant women. Animal studies showed no adverse developmental effects at clinically relevant doses.
Pediatric Use

Pediatric Use

≥13 years
Warnings Tab

Contraindications, side effects, etc.

Contraindications: Information not available. Warnings: Information not available. Side Effects: Less common side effects include blurred vision, painful irritation of the eye, redness of the white part of the eyes or the inside of the eyelids. Other side effects include dry eye, headache, and pain at the instillation site​​.